Hospital-Acquired Infections Differential Diagnoses

1. Mahieu LM, De Muynck AO, Ieven MM, De Dooy JJ, Goossens HJ, Van Reempts PJ. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect. 2001 Jun. 48(2):108-16. [QxMD MEDLINE Link].

2. Newman CD. Catheter-related bloodstream infections in the pediatric intensive care unit. Semin Pediatr Infect Dis. 2006 Jan. 17(1):20-4. [QxMD MEDLINE Link].

3. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000 Apr. 19(4):319-24. [QxMD MEDLINE Link].

4. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics. 2002 May. 109(5):758-64. [QxMD MEDLINE Link].

5. Fayon MJ, Tucci M, Lacroix J, et al. Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: a prospective study. Am J Respir Crit Care Med. 1997 Jan. 155(1):162-9. [QxMD MEDLINE Link].

6. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics. 2003 Dec. 112(6 Pt 1):1283-9. [QxMD MEDLINE Link].

7. Moulin F, Quintart A, Sauvestre C, Mensah K, Bergeret M, Raymond J. [Nosocomial urinary tract infections: retrospective study in a pediatric hospital]. Arch Pediatr. 1998. 5 Suppl 3:274S-278S. [QxMD MEDLINE Link].

8. Zaoutis TE, Coffin SE. Clinical Syndromes of Device-Associated Infections. Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Churchill Livingstone; 2008. chap 102.

9. Coffin SE, Zaoutis TE. Healthcare-Associated Infections. Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Churchill Livingstone; 2008. chap 101.

10. Hospital Infections Program, National Center for Infectious Diseases, CDC. Public Health Focus: surveillance, prevention, and control of nosocomial infections. MMWR. October 1992. 41(42):783-787.

11. Hughes JM. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Chemotherapy. 1988. 34(6):553-61. [QxMD MEDLINE Link].

12. Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control. 2008 Nov. 36(9):609-26. [QxMD MEDLINE Link].

13. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics. 1999 Apr. 103(4):e39. [QxMD MEDLINE Link].

14. Lessa FC, Mu Y, Ray SM, et al. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections. Clin Infect Dis. 2012 Jul. 55 (2):232-41. [QxMD MEDLINE Link].

15. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008 Jun. 36(5):309-32. [QxMD MEDLINE Link].

16. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 2001 Mar-Apr. 7(2):174-7. [QxMD MEDLINE Link]. [Full Text].

17. Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr. 2002 Apr. 140(4):432-8. [QxMD MEDLINE Link].

18. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, Grohskopf LA, Levine GL, Stover BH. Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr. 2001 Dec. 139(6):821-7. [QxMD MEDLINE Link].

19. Barclay L. Healthcare-acquired infections fall in critically ill kids. Medscape Medical News. September 8, 2014. [Full Text].

20. Patrick S, Kawai A, Kleinman K, et al. Health care-associated infections among critically ill children in the US, 2007–2012. Pediatrics. 2014 Sep 8. [Epub ahead of print]:

21. CDC. National and State Healthcare-associated Infections Progress Report. Mar 2014. Available at http://www.cdc.gov/hai/progress-report/.

22. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014 Mar 27. 370(13):1198-208. [QxMD MEDLINE Link].

23. Tikhomirov E. WHO programme for the control of hospital infections. Chemioterapia. June 1987. 6(3):148-51.

24. Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control. 2008 Nov. 36(9):627-37. [QxMD MEDLINE Link].

25. Aiken AM, Mturi N, Njuguna P, Mohammed S, Berkley JA, Mwangi I, et al. Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study. Lancet. 2011 Dec 10. 378(9808):2021-7. [QxMD MEDLINE Link].

26. Sahiledengle B, Seyoum F, Abebe D, et al. Incidence and risk factors for hospital-acquired infection among paediatric patients in a teaching hospital: a prospective study in southeast Ethiopia. BMJ Open. 2020 Dec 17. 10 (12):e037997. [QxMD MEDLINE Link].

27. Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect. 2006 Sep. 64(1):16-22. [QxMD MEDLINE Link].

28. Klevens RM, Edwards JR, Richards CL, et al. Estimating healthcare-associated infections in US hospitals, 2002. Public Health Rep. Mar 2007. 122(2):160-6.

29. Scott RD. The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention, 2008. CDC. Available at http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf. Accessed: 7/1/2009.

30. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011 Mar 4. 60(8):243-8. [QxMD MEDLINE Link].

31. Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, et al. Dressing disruption is a major risk factor for catheter-related infections*. Crit Care Med. 2012 Jun. 40(6):1707-1714. [QxMD MEDLINE Link].

32. Craven DE, Chroneou A, Zias N, Hjalmarson KI. Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes. Chest. 2009 Feb. 135(2):521-8. [QxMD MEDLINE Link].

33. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005 Feb 15. 171(4):388-416. [QxMD MEDLINE Link].

34. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003 Nov 19. 290(19):2588-98. [QxMD MEDLINE Link].

35. Mullin KM, Kovacs CS, Fatica C, Einloth C, Neuner EA, Guzman JA, et al. A Multifaceted Approach to Reduction of Catheter-Associated Urinary Tract Infections in the Intensive Care Unit With an Emphasis on "Stewardship of Culturing". Infect Control Hosp Epidemiol. 2016 Nov 17. 1-3. [QxMD MEDLINE Link].

36. Boggs W. Focus on Appropriate Urine Cultures May Cut Catheter-Associated UTI Rates. Reuters Health Information. Available at http://www.medscape.com/viewarticle/872810. December 7, 2016; Accessed: December 8, 2016.

37. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. CDC. Available at http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Isolation2007.pdf. Accessed: 7/9/2009.

38. Committee on Infectious Diseases, American Academy of Pediatrics. Pickering LK. Red Book 2006. 27th ed. American Academy of Pediatrics; 2006. 153-160.

39. [Guideline] Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections, 2011. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdf. Accessed: January 31 2013.

40. Piper HG, Wales PW. Prevention of catheter-related blood stream infections in children with intestinal failure. Curr Opin Gastroenterol. 2013 Jan. 29(1):1-6. [QxMD MEDLINE Link].

41. Sanders J, Pithie A, Ganly P, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother. 2008 Oct. 62(4):809-15. [QxMD MEDLINE Link].

42. Hand L. Catheter disinfection caps cut infection rates. Medscape Medical News. Jan 4, 2013. Available at http://www.medscape.com/viewarticle/777186. Accessed: Jan 16, 2013.

43. Wright MO, Tropp J, Schora DM, Dillon-Grant M, Peterson K, Boehm S, et al. Continuous passive disinfection of catheter hubs prevents contamination and bloodstream infection. Am J Infect Control. 2013 Jan. 41(1):33-8. [QxMD MEDLINE Link].

44. Loftus RW, Brindeiro BS, Kispert DP, et al. Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system. Anesth Analg. 2012 Dec. 115(6):1315-23. [QxMD MEDLINE Link].

45. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004 Mar 26. 53:1-36. [QxMD MEDLINE Link].

46. Wong ES, Hooton TM. Guideline for prevention of catheter-associated urinary tract infections. CDC. Available at http://www.cdc.gov/ncidod/dhqp/gl_catheter_assoc.html. Accessed: 7/7/2009.

47. Passaretti CL, Otter JA, Reich NG, Myers J, Shepard J, Ross T, et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis. 2013 Jan. 56(1):27-35. [QxMD MEDLINE Link].

48. Pullen LC. H2O2 Vapor Technology Improves Hospital Infection Control. Available at http://www.medscape.com/viewarticle/777738. Accessed: March 13, 2013.

49. Maziade PJ, Andriessen JA, Pereira P, et al. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital. Curr Med Res Opin. 2013 Oct. 29(10):1341-7. [QxMD MEDLINE Link].

50. Nierengarten M. Ultraviolet Disinfection Cuts Hospital-Acquired Infections. Medscape Medical News. Available at http://www.medscape.com/viewarticle/825949. Accessed: June 9, 2014.

51. Haas JP, Menz J, Dusza S, Montecalvo MA. Implementation and impact of ultraviolet environmental disinfection in an acute care setting. Am J Infect Control. 2014 Jun. 42(6):586-90. [QxMD MEDLINE Link].

Haidee T Custodio, MD Associate Professor, Department of Pediatrics, Division of Pediatric Infectious Diseases, University of South Alabama College of Medicine

Haidee T Custodio, MD is a member of the following medical societies: American Academy of Pediatrics, Infectious Diseases Society of America, Pediatric Infectious Diseases Society

Disclosure: Local Principal Investigator for a clinical trial for: Allergan.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Joseph Domachowske, MD Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa

Disclosure: Received research grant from: Pfizer;GlaxoSmithKline;AstraZeneca;Merck;American Academy of Pediatrics, Novavax, Regeneron, Diassess, Actelion<br/>Received income in an amount equal to or greater than $250 from: Sanofi Pasteur.

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

The authors and editors of Medscape Drugs & Diseases gratefully acknowledge the contributions of previous author Ayesha Mirza, MD, to the development and writing of this article.

• Print this section
• Print the entire contents of
• Print the entire contents of article